CHINOOK THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Chinook Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Chinook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $9.19M, a 93.1% increase year-over-year.
  • Chinook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $28.1M, a 78.7% increase year-over-year.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.1M, a 56.9% increase from 2021.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.8M, a 254% increase from 2020.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $3.61M, a 3701% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $20.1M +$7.27M +56.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 $12.8M +$9.17M +254% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 $3.61M +$3.52M +3701% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $95K -$17.4M -99.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-07
2018 $17.5M +$1.1M +6.71% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $16.4M +$1.37M +9.13% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $15M +$6.58M +78% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $8.43M +$7.86M +1379% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $570K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.